CFTY720D2406: Long-term, prospective, non-interventional, multinational, parallel cohort study monitoring safety in patients with MS recently initiated with fingolimod once daily or treated with another approved disease-modifying therapy

Trial Profile

CFTY720D2406: Long-term, prospective, non-interventional, multinational, parallel cohort study monitoring safety in patients with MS recently initiated with fingolimod once daily or treated with another approved disease-modifying therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Fingolimod (Primary) ; Immunosuppressants
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by United Kingdom Clinical Research Network.
    • 11 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top